Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists

Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists

US Patent 9593118 · Granted Mar 14, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic amide-containing pyridyl xanthines as A2B antagonists2025
Cyclic amide-containing pyridyl xanthines as A2B antagonists2023
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2017
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2017
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2017
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2015
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2015
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2015
Methods for the synthesis of unsymmetrical cycloakyl substituted xanthines2013
Methods for the synthesis of unsymmetrical cycloakyl substituted xanthines2013
Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines2013
Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines2013